Cargando…
Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
BACKGROUND: Despite the great clinical response to the first-line chemotherapeutics, metastasis still happens among most of the ovarian cancer patients within 2 years. METHODS: Using multiple human ovarian cancer cell lines, a transwell co-culture system of the carboplatin or VP-16-challenged feeder...
Autores principales: | Zhao, Yawei, He, Meihui, Cui, Lianzhi, Gao, Mohan, Zhang, Min, Yue, Fengli, Shi, Tongfei, Yang, Xuehan, Pan, Yue, Zheng, Xiao, Jia, Yong, Shao, Dan, Li, Jing, He, Kan, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250874/ https://www.ncbi.nlm.nih.gov/pubmed/32242101 http://dx.doi.org/10.1038/s41416-020-0825-7 |
Ejemplares similares
-
Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway
por: Cui, Lianzhi, et al.
Publicado: (2017) -
Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway
por: Wen, Haiyan, et al.
Publicado: (2020) -
Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer
por: Peng, Chaozhong, et al.
Publicado: (2021) -
AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1
por: Xu, Menglin, et al.
Publicado: (2020) -
Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer
por: Trnski, Diana, et al.
Publicado: (2019)